Volume | 847,337 |
|
|||||
News | - | ||||||
Day High | 93.64 | Low High |
|||||
Day Low | 91.41 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Natera Inc | NTRA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
91.87 | 91.41 | 93.64 | 91.50 | 91.04 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
17,699 | 847,337 | $ 92.27 | $ 78,180,270 | - | 36.90 - 98.82 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:22:22 | 50 | $ 91.38 | USD |
Natera (NTRA) Options Flow Summary
Natera Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
11.04B | 120.76M | - | 1.08B | -434.8M | -3.60 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Natera News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NTRA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 91.06 | 93.64 | 83.13 | 87.73 | 1,338,329 | 0.44 | 0.48% |
1 Month | 90.40 | 98.82 | 83.13 | 91.86 | 1,263,127 | 1.10 | 1.22% |
3 Months | 65.50 | 98.82 | 64.74 | 84.89 | 1,442,421 | 26.00 | 39.69% |
6 Months | 40.38 | 98.82 | 36.90 | 69.94 | 1,431,389 | 51.12 | 126.60% |
1 Year | 54.90 | 98.82 | 36.90 | 61.16 | 1,268,540 | 36.60 | 66.67% |
3 Years | 112.12 | 129.09 | 26.10 | 59.38 | 1,333,988 | -20.62 | -18.39% |
5 Years | 19.32 | 129.09 | 16.87 | 58.05 | 1,102,238 | 72.18 | 373.60% |
Natera Description
Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result. |